Kuhn v. WillfordKuhn v. Willford
- Reporters:
- Before:
- Esther Salas
SALAS, DISTRICT JUDGE
Before the Court is defendant Jovan Willford‘s (“Defendant“) motion to dismiss (D.E. No. 14 (“Motion” or “Mot.“)) plaintiff Peter Kuhn‘s (“Plaintiff“) Complaint (D.E. No. 1 (“Complaint” or “Compl.“)). Plaintiff filed an opposition (D.E. No. 19 (“Opp. Br.“)), and Defendant filed a reply (D.E. No. 23 (“Reply Br.“)). Having considered the parties’ submissions, the Court decides Defendant‘s Motion without oral argument. See
I. BACKGROUND
A. Factual Background1
Plaintiff is an individual who currently resides in Alabama and who has over twenty-five years of experience in the healthcare technology industry. (Compl. ¶¶ 8 & 12). In December 2020, Plaintiff became the Chief Sales and Growth Officer of Healthgrades. (Id. ¶ 19). Defendant is an individual who currently resides in New Jersey and was hired as the Chief Executive Officer
At some point, Defendant hired A&M Consulting to do a financial review of the remaining business at Mercury Healthcare,2 and “[u]pon information and belief, A&M Consulting immediately discovered that the leftover business at Mercury was losing $30 million annually (a surprise to the Board) and was suffering with major product and customer satisfaction issues on two primary product lines.” (Id. ¶¶ 23-24). Based on A&M Consulting‘s recommendations, from August 2021 to December 2021, Plaintiff initiated a cost-cutting plan to reduce sales and certain staff members. (Id. ¶ 31).
From mid-November 2021 through December 2021, Defendant briefly “disappeared” from the Company after presenting a grim financial plan to the Board of Directors, and during this time “there was a rumor of a Board-initiated fire sale spreading through the management team[.]” (Id. ¶ 33). Defendant “suddenly reappear[ed]” in December 2021 and held a meeting with upper management and the executive team members, stating that private equity firm Vestar Capital Partners had agreed to invest up to $30 million in the Company over three years to help fund its turnaround. (Id. ¶ 34). Defendant subsequently presented a five-year plan that included “killing off” two of the Company‘s major product lines. (Id. ¶ 35). Plaintiff had concerns about this plan, and at some point following this meeting, he approached Defendant and “asked Defendant if the Company was committed to a turnaround or if it was instead being positioned for a sale.” (Id. ¶
At some point “[p]rior to December 2021, Defendant learned that the Company intended to sell its assets to WebMD and that plans had been put into place to do so[,]” which “plans included substantial bonuses for the chief executives of the Company.” (Id. ¶ 3). Shortly after Defendant learned about this intended sale, all the other chief officers of the Company—excluding Plaintiff—were also informed of the intended sale. (Id. ¶ 4).
From December 2021 through March 2022, Plaintiff had a series of conversations with Defendant regarding the then-current direction of the Company and its effect on the Company‘s culture. (Id. ¶ 45). According to Plaintiff, Defendant created a hostile work environment for him during this time by instructing him to make “cold calls” to potential customers and to complete other tasks more frequently reserved for lower-level employees, in an effort to force him to resign. (Id. ¶¶ 46-49, 52 & 61). Plaintiff was also “uninvited” to the Q4 2021 Board of Directors meeting, and at some point after that meeting he again approached Defendant and asked him if he was planning to sell the Company. (Id. ¶¶ 50 & 53). Defendant again told Plaintiff that the Company was not going to be sold and was committed to a turnaround. (Id. ¶ 53).
On March 10, 2022, Plaintiff submitted his resignation notice “[a]s a result of Defendant‘s hostile treatment of [him], and in response to Defendant‘s stated intent to pursue a fatally flawed turnaround plan[.]” (Id. ¶ 54). Plaintiff‘s last day at the Company was April 1, 2022. (Id. ¶ 55).
Plaintiff alleges that Defendant “intentionally suppressed” certain information from him that caused him to resign from his position as CRO of the Company. (See generally Compl.). Specifically, Plaintiff alleges (i) that Defendant “suppressed” from him the fact that in December 2021 the Company executed a letter of intent to be sold to WebMD; (ii) that, when asked, Defendant told Plaintiff the Company was not going to be sold and instead was committed to a five-year turnaround plan; (iii) that Defendant‘s suppression of information, along with the hostile work environment he created for Plaintiff, ultimately induced Plaintiff to resign from the Company, effective April 1, 2022; and (iv) that Plaintiff lost out on a “multi-million dollar” deal bonus as a result of Defendant‘s actions. (See id.). Plaintiff states that but for having been fraudulently misled by Defendant, he would not have resigned and would have “received a multi-million dollar bonus.” (Id. ¶ 6; see also id. ¶¶ 3-4, 38, 41-64 & 66-75). According to Plaintiff, Defendant intended to force him to resign “so that Defendant could avoid paying Plaintiff a deal bonus payout from the sale of the Company to WebMD and instead, keep that money for himself.” (Id. ¶ 63).
B. Procedural History
On February 27, 2024, Plaintiff initiated this action by filing the Complaint against Defendant, asserting one cause of action titled “Fraudulent Suppression/Deceit.”4 (See generally
II. LEGAL STANDARD
A. Rule 12(b)(6)
In assessing whether a complaint states a cause of action sufficient to survive dismissal under
While the Court generally “may not consider matters extraneous to the pleadings” when deciding a
B. Rule 9(b) Heightened Pleading Standard
III. DISCUSSION
Defendant moves to dismiss Plaintiff‘s Complaint for failure to state a claim, pursuant to
In opposition, Plaintiff argues (i) Defendant wrongly asserts that fraudulent suppression is
In reply, Defendant (i) reiterates that the Complaint fails to meet
Here, the Court does not reach the choice-of-law issue because it finds that irrespective of
Additionally, the Court finds Plaintiff‘s Complaint otherwise fails to plausibly state a claim for fraud under New Jersey law—whether common law fraud, fraudulent inducement, fraudulent concealment, or otherwise—sufficient to withstand a
Second, to the extent Plaintiff intended to bring a claim under New Jersey law for common law fraud, fraudulent inducement, or fraudulent misrepresentation, Plaintiff‘s Complaint fails to adequately state such a claim. “The standard for establishing a claim of common law fraud,
Further, the Complaint does not allege that Defendant made these statements with the intent that Plaintiff would rely on them. For instance, the Complaint does not allege that Plaintiff ever told Defendant that he was considering resigning or that Plaintiff and Defendant ever had any
Therefore, the Court finds Plaintiff‘s Complaint fails to adequately state a claim for fraudulent inducement, fraudulent misrepresentation, or common law fraud under New Jersey law.7
Third, to the extent Plaintiff alternatively intended to bring a fraudulent concealment or fraudulent omission claim under New Jersey law, Plaintiff‘s Complaint likewise fails to state such a claim. “To state a claim for fraudulent concealment under New Jersey law, a plaintiff must allege: (1) a legal duty to disclose (2) a material fact (3) that plaintiff could not discover without defendant disclosing it; (4) that defendant intentionally failed to disclose that fact; and (5) that plaintiff was harmed by relying on the non-disclosure.” Polhill v. FedEx Ground Package Sys., 604 F. App‘x 104, 108 n.2 (3d Cir. 2015) (citing Rosenblit v. Zimmerman, 766 A.2d 749, 757-58 (N.J. 2001)); see also United Cap. Funding Grp., LLC v. Remarkable Foods, LLC, No. 21-3291, 2023 WL 5722910, at *4 (D.N.J. Sept. 5, 2023). Similarly, “[t]o state a fraudulent omission claim, plaintiffs generally must establish that the defendant had a duty to disclose the omitted information.” Cohen v. Subaru of Am., Inc., No. 20-8442, 2022 WL 721307, at *19 (D.N.J. Mar. 10, 2022) (citing Clark v. Prudential Ins. Co. of Am., 289 F.R.D. 144, 184 (D.N.J. 2013)); see also Ramirez v. World Mission Soc‘y, Church of God, No. 14-1708, 2024 WL 1366445, at *5 (D.N.J. Apr. 1, 2024) (“In New Jersey, fraudulent omission claims require the defendant to have a duty to disclose the omitted information.” (citations omitted)). “Three general classes of transactions give rise to a duty to disclose“: (i) “fiduciary relationships such as attorney and client“; (ii) “where, because of the nature of the transaction or the parties’ position toward each other, ‘trust and confidence ... is necessarily implied‘“; and (iii) “where contracts or transactions are ‘intrinsically fiduciary’ because of their ‘essential nature’ and thus ‘necessarily call [] for perfect good faith and full disclosure, without regard to any particular intention of the parties.‘” Ramirez, 2024 WL 1366445, at *5 (alterations in original) (citation omitted).
One common element of both of these causes of action is that the plaintiff must allege that the defendant had a duty to disclose. Here, Plaintiff‘s Complaint does not allege any facts showing Defendant owed Plaintiff a duty to disclose information regarding the Company‘s alleged future plan to be sold to WebMD, nor does it allege any facts regarding a relationship between Plaintiff and Defendant that would have created such a duty. Therefore, the Court finds Plaintiff‘s Complaint similarly fails to adequately state a claim for fraudulent concealment or fraudulent omission under New Jersey law. See, e.g., Pushkin v. Nussbaum, No. 12-0324, 2017 WL 1591863, at *8 (D.N.J. Apr. 28, 2017), report and recommendation adopted, 2018 WL 500145 (D.N.J. Jan. 19, 2018) (“Plaintiff completely fails to allege the essential elements of a claim for fraud such that he does not meet the pleading requirement of Fed. R. Civ. P. 8, let alone the more heightened pleading standard of
In sum, the Court finds Plaintiff‘s Complaint fails to meet
IV. CONCLUSION
Based on the foregoing, Defendant‘s Motion to Dismiss is GRANTED, and accordingly Plaintiff‘s Complaint is DISMISSED without prejudice. Within thirty (30) days of the date of this Opinion, Plaintiff may file an amended complaint curing the deficiencies outlined herein. An appropriate Order follows.
Dated: June 30, 2025
/s/ Esther Salas
Esther Salas, U.S.D.J.